These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11916358)

  • 21. Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings.
    Fasullo S; Cannizzaro S; Maringhini G; Ganci F; Giambanco F; Vitale G; Pinto V; Migliore G; Torres D; Sarullo FM; Paterna S; Di Pasquale P
    J Card Fail; 2009 Dec; 15(10):856-63. PubMed ID: 19944362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diltiazem on cardiac remodeling in rats assessed by Doppler echocardiography and mRNA expression.
    Yoshiyama M; Takeuchi K; Omura T; Izutani S; Nakamura Y; Akioka K; Kim S; Iwao H; Yoshikawa J
    Cardiovasc Drugs Ther; 1999 May; 13(3):249-58. PubMed ID: 10439888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early invasive strategy in patients with myocardial infarction and intraventricular conduction disturbances and plasma B-type natriuretic peptide levels assessed 6 months after myocardial infarction].
    Ciuraszkiewicz K; Sielski J; Janion-Sadowska A; Sadowski M; Janion M
    Pol Merkur Lekarski; 2012 May; 32(191):293-7. PubMed ID: 22779334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
    Kleber FX; Nussberger J; Niemöller L; Doering W
    Cardiology; 1992; 81(4-5):213-20. PubMed ID: 1301246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human recombinant-B-type natriuretic peptide protect ventricular function and structure in ST-elevation myocardial infarction.
    Gong X; Mou Z; Shao L; Zou Y; Gu Y; Sun S
    Int J Clin Exp Pathol; 2015; 8(9):11622-8. PubMed ID: 26617900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Ivabradine on Cardiac Function after Myocardial Infarction are Weaker in Diabetic Rats.
    Cao X; Sun Z; Zhang B; Li X; Xia H
    Cell Physiol Biochem; 2016; 39(5):2055-2064. PubMed ID: 27825166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
    Gambelli G; Donati R; Mezzanotte R; Pozzar F; Cesario AS; Schiavo B; Pau F
    G Ital Cardiol; 1998 Mar; 28(3):249-58. PubMed ID: 9561879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.
    Tingberg E; Roijer A; Thilen U; Ohlin H
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):166-72. PubMed ID: 17086095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide.
    McNairy M; Gardetto N; Clopton P; Garcia A; Krishnaswamy P; Kazanegra R; Ziegler M; Maisel AS
    Am Heart J; 2002 Mar; 143(3):406-11. PubMed ID: 11868044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
    Nagaya N; Nishikimi T; Goto Y; Miyao Y; Kobayashi Y; Morii I; Daikoku S; Matsumoto T; Miyazaki S; Matsuoka H; Takishita S; Kangawa K; Matsuo H; Nonogi H
    Am Heart J; 1998 Jan; 135(1):21-8. PubMed ID: 9453517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
    Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
    Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
    Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
    Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
    Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S
    J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction.
    Luo D; Hu H; Qin Z; Liu S; Yu X; Ma R; He W; Xie J; Lu Z; He B; Jiang H
    Auton Neurosci; 2017 Dec; 208():73-79. PubMed ID: 28941985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty.
    Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K
    J Cardiol; 2003 Nov; 42(5):195-200. PubMed ID: 14658407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.